chr19-4094777-G-C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030662.4(MAP2K2):c.1047-279C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 33) 
 Exomes 𝑓:  0.0   (  0   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 MAP2K2
NM_030662.4 intron
NM_030662.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.388  
Publications
16 publications found 
Genes affected
 MAP2K2  (HGNC:6842):  (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008] 
MAP2K2 Gene-Disease associations (from GenCC):
- cardiofaciocutaneous syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- cardiofaciocutaneous syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Noonan syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MAP2K2 | NM_030662.4 | c.1047-279C>G | intron_variant | Intron 9 of 10 | ENST00000262948.10 | NP_109587.1 | ||
| MAP2K2 | NM_001440688.1 | c.768-279C>G | intron_variant | Intron 7 of 8 | NP_001427617.1 | |||
| MAP2K2 | NM_001440689.1 | c.477-279C>G | intron_variant | Intron 7 of 8 | NP_001427618.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF:  0.00  AC: 0AN: 364184Hom.:  0  Cov.: 1 AF XY:  0.00  AC XY: 0AN XY: 189424 
GnomAD4 exome 
Data not reliable, filtered out with message: AC0
 AF: 
AC: 
0
AN: 
364184
Hom.: 
Cov.: 
1
 AF XY: 
AC XY: 
0
AN XY: 
189424
African (AFR) 
 AF: 
AC: 
0
AN: 
11148
American (AMR) 
 AF: 
AC: 
0
AN: 
15672
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
11734
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
26092
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
37980
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
22364
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
1584
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
216052
Other (OTH) 
 AF: 
AC: 
0
AN: 
21558
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
33
Alfa 
 AF: 
Hom.: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.